Evicenter
MarkdownMedical informationP&T meetings
Vonaprument (ANX007)

Geographic atrophy secondary to age-related macular degeneration

Launch
Not announced
Last updated
167 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Geographic atrophy secondary to age-related macular degeneration

Economic burden and healthcare resource utilization

8 evidence topics · 9 sources

Healthcare resource utilization rate ratios: United States Medicare Advantage claims
Societal cost of illness per person with geographic atrophy: United States estimate
Direct and indirect ophthalmic resource use and costs: United Kingdom, Germany, Ireland, and Canada